Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Tryptophan as a Modulating Factor in the Antimigraine Efficacy of Triptans

View source ↗

Summary

A clinical trial is investigating whether tryptophan modulates the efficacy of triptans for migraine and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triptans (triptans)
  • Tryptophan (tryptophan)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Migraine | Status: RECRUITING